By the end of this video, you will be able to define
the idea of toxicology. You'll be able to differentiate between toxicology
and pharmacology. Finally, you will be able
to describe the role of toxicology in a
drug hunting program. Paracelsus was a
historical figure, and generally considered to
be the father of toxicology. During Paracelsus' lifetime
from 1493 to 1541, Paracelsus studied medicine,
theology, and philosophy. A famous quote attributed
to Paracelsus is in Latin, sola dosis facit venenum, in English, the quote means only the dose makes the poison. In its full context, Paracelsus quote
points out that drugs, when used at too high
of a dose can carry toxic risks that outweigh the
drug's potential benefits. The idea that a drug may
not be completely free of safety risks may
seem counter-intuitive. Yet all drugs carry
some degree of risk, even at therapeutic doses, no matter how small. The US Food and
Drug Administration approves new drugs
based on their benefits outweighing the known
and potential risks for the intended population. The intended population is
an important consideration, and indicates safety risks are evaluated in the context of
the disease being treated. Referring back to Paracelsus, exceeding the approved
therapeutic doses for a drug can lead to significant adverse
events as can using a drug for an
unapproved indication. Toxicology guides
the understanding of the safety risks of a drug. But what is toxicology? Toxicology is the
study of poisons. In the context of
drug discovery, toxicology focuses on
the potential toxic, poisonous effects
of molecules that are being considered
as potential drugs. In contrast, the
field of pharmacology emphasizes the
therapeutic benefits, not the toxicity of
potential drugs. Both Toxicology and Pharmacology are essential fields
for drug development. Pharmacology is needed to understand the molecule's
therapeutic benefit, toxicology is needed to
understand safety risks. While pharmacology
focuses on the action of molecules on the
intended target protein, toxicological studies
must be open to toxicity from the
intended target, its associated pathways, and off target effects. Within a drug program, scientists who study a
molecule's toxicology are part of the
pre-clinical safety group. The term pre-clinical can be
misleading as the efforts of a pre-clinical safety
team continue even while a molecule is being studied in humans, in clinical trials. Because some pre-clinical
safety studies are concurrent with
clinical trials, some in drug discovery prefer the term non-clinical safety
over pre-clinical safety. Understanding of molecule's
toxicology is just as important as its pharmacology
for regulatory approval. All drugs have safety risks, and toxicologists not
only identify the risks, but also determine the dosages, concentrations, and exposures
that can lead to toxicity.